Please login to the form below

Not currently logged in
Email:
Password:

The Partners

This page shows the latest The Partners news and features for those working in and with pharma, biotech and healthcare.

AZ claims first-in-class win for Farxiga in heart failure

AZ claims first-in-class win for Farxiga in heart failure

$2.7bn for the two partners in 2018 after becoming the first drug in the class to show an impact on cardiovascular outcomes. ... The two partners also have another pair of trials under the EMPERIAL banner looking at exercise capacity and heart failure

Latest news

  • Basilea moves closer to US filing of novel antibiotic Basilea moves closer to US filing of novel antibiotic

    Analysts at Goetz Partners say however that the US is “the key market for MRSA antibiotics and accounts for 56% of our peak sales estimate for the drug… due mainly to ... the high incidence of MRSA in US hospitals and the higher propensity in the US

  • CHMP backs Bayer’s tumour-agnostic drug Vitrakvi CHMP backs Bayer’s tumour-agnostic drug Vitrakvi

    The two partners are trying to build a lead in both markets over Roche’s rival drug entrectinib, currently being reviewed by the FDA as a second-line option after Vitrakvi, ... Empliciti was approved in the US for this indication with a breakthrough

  • J&J files new Darzalex formulation in US and Europe J&J files new Darzalex formulation in US and Europe

    will also be suitable for use in Darzalex treatment failures as it targets a different part of the CD38 molecule. ... The antibody was originally developed by Danish biotech Genmab, and last month J&J also took an option on a follow-up drug –

  • Boehringer taps Korea’s Bridge for Ofev follow-up Boehringer taps Korea’s Bridge for Ofev follow-up

    is the approved indication for Ofev (nintedanib) and affects around 3m people worldwide. ... The partners intend to advance BBT-877 into a phase 2 trial later this year.

  • Illumina sets up first ex-US accelerator site in Cambridge Illumina sets up first ex-US accelerator site in Cambridge

    Cambridge is of course also where Illumina was carrying out the DNA sequencing for the UK’s 100, 000 Genomes Project, in collaboration with Genomics England and other partners such as ... Illumina is joining forces with several venture firms for the

More from news
Approximately 1 fully matching, plus 589 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 82 partially matching documents found.

Latest appointments

  • Dr Martin Rothman joins Sofinnova Partners Dr Martin Rothman joins Sofinnova Partners

    Rothman brings 40 years of experience along with an international network in the medical field to Sofinnova Partners. ... Commenting on the appointment, Antoine Papiernik, managing partner and chairman of Sofinnova Partners, said: “Martin is an

  • Unlimited Group appoints group managing director Unlimited Group appoints group managing director

    Richards joins the group from VCCP, where he held the role of international managing director. ... Richards will head the group’s partners’ board and will report into the group Chairman Ian Ferguson.

  • PureTech Health appoints new chief financial officer PureTech Health appoints new chief financial officer

    Joep Muijrers joins the biopharma from Life Sciences Partners. Clinical-stage biopharmaceutical company PureTech Health has bolstered the team with a new chief financial officer in the form of Joep Muijrers. ... Muijrers most recently served as a partner

  • Professor Carole Longson moves from NICE to the ABPI Professor Carole Longson moves from NICE to the ABPI

    and the role our members play in developing new innovative medicines and vaccines. ... experience, expertise and network in both industry and academia will enable the ABPI to work with our partners to further these objectives.”.

  • Lexington Communications bolsters team with a trio of new-hires Lexington Communications bolsters team with a trio of new-hires

    of the ever-changing health landscape to provide invaluable strategic advise and insider analysis to our existing and potential clients.”. ... Our new senior advisors will join a team that has the reputation of being one of the best in the market, and

More from appointments
Approximately 1 fully matching, plus 24 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 71 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics